tldrdailynews.com logo

FDA Panel Reviews MDMA Therapy for PTSD

1 min read
Source: Psychedelic Alpha
FDA Panel Reviews MDMA Therapy for PTSD
Photo: Psychedelic Alpha
TL;DR

The FDA’s Psychopharmacologic Drugs Advisory Committee is reviewing Lykos Therapeutics’ New Drug Application for MDMA-assisted therapy for PTSD. The meeting includes presentations from both the FDA and Lykos, public comments, and a vote on two questions that could influence the FDA's decision on August 11th. Key discussions involve the role of psychotherapy, trial misconduct, patient recruitment, and safety concerns. The meeting is being live-streamed on YouTube, with periodic updates provided by Psychedelic Alpha's Founder & Editor, Josh Hardman.

Topics:businesshealth#fda#health#lykos-therapeutics#mdma#psychotherapy#ptsd
Share this article
  1. Live Coverage: FDA Advisory Committee Reviews MDMA-Assisted Therapy for PTSD  Psychedelic Alpha
  2. Up First briefing: MDMA for PTSD treatment; Biden's border policy  NPR
  3. FDA advisers consider MDMA therapy to treat PTSD  CNN
  4. Psychedelics Are Challenging the Scientific Gold Standard  The Atlantic
  5. Controversy Grows as FDA Panel Prepares to Review MDMA Drug  Medscape

Want the full story? Read the original reporting

Read on Psychedelic Alpha